NR4A1 is reported to be largely absent in leukemia and lymphoma yet highly expressed in a myriad of solid tumors, specifically in solid tumors with enhanced metabolic rate, with elevated NR4A1 expression acting as a negative prognostic marker in affected patients50. This evidence concerns the gene NR4A1 and lymphoma.